Becky Schweighardt Selected Research

Hemophilia A (Haemophilia)

1/2021	Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A.
6/2019	The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Becky Schweighardt Research Topics

Disease

7	Infections 04/2010 - 11/2005
5	Hypersensitivity (Allergy) 12/2018 - 05/2015
3	Phenylketonurias (Phenylketonuria) 01/2021 - 11/2018
3	Anaphylaxis (Anaphylactic Shock) 11/2018 - 05/2015
3	Mucopolysaccharidoses 01/2017 - 12/2014
2	Hemophilia A (Haemophilia) 01/2021 - 06/2019
2	Mucopolysaccharidosis IV (Morquio Syndrome) 05/2015 - 12/2014
2	Disease Progression 04/2010 - 01/2010
2	Viremia 04/2009 - 06/2006
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 12/2003 - 11/2002
1	Food Hypersensitivity (Food Allergy) 11/2018
1	Communicable Diseases (Infectious Diseases) 11/2018
1	Immune Complex Diseases (Immune Complex Disease) 11/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2010
1	Superinfection 06/2006
1	HIV Infections (HIV Infection) 06/2006
1	Persistent Infection 06/2006

Drug/Important Bio-Agent (IBA)

5	EnzymesIBA 01/2021 - 12/2014
4	Immunoglobulin E (IgE)IBA 12/2018 - 05/2015
3	Phenylalanine (L-Phenylalanine)FDA Link 01/2021 - 11/2018
3	pegvaliaseIBA 01/2021 - 11/2018
3	Pharmaceutical PreparationsIBA 12/2018 - 11/2002
3	AntibodiesIBA 01/2017 - 01/2010
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2021 - 11/2018
2	human GALNS proteinIBA 01/2017 - 05/2015
2	GlycosaminoglycansIBA 05/2015 - 12/2014
2	Keratan SulfateIBA 05/2015 - 12/2014
2	Viral RNAIBA 04/2010 - 04/2009
2	Neutralizing AntibodiesIBA 04/2010 - 06/2006
2	VaccinesIBA 04/2010 - 09/2007
2	RNA (Ribonucleic Acid)IBA 04/2009 - 12/2003
1	Valoctocogene RoxaparvovecIBA 01/2021
1	B-domain-deleted factor VIIIIBA 06/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2018
1	Antigen-Antibody Complex (Immune Complex)IBA 11/2018
1	Ammonia-LyasesIBA 11/2018
1	Sulfates (Sulfates, Inorganic)IBA 05/2015
1	Keratins (Keratin)IBA 05/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2005
1	Peptide Hydrolases (Proteases)FDA Link 11/2002

Therapy/Procedure

3	Therapeutics 01/2010 - 11/2002
1	Enzyme Replacement Therapy 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 12/2003